Last 705.85 INR
Change Today -0.85 / -0.12%
Volume 480.3K
GNP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glenmark pharmaceuticals ltd (GNP)

Year over year, Glenmark Pharmaceuticals Ltd. has seen their bottom line shrink from 6.2B INR to 5.4B INR despite an increase in revenues from 49.7B INR to 59.4B INR. An increase in the percentage of sales devoted to income tax expenses from 2.23% to 2.54% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
Restated
INR
Mar 31
2012
Reclassified
INR
Mar 31
2013
Restated
INR
Mar 31
2014
INR
4 Year
Trend
Revenues29,490.740,206.449,691.459,449.5
Other Revenues99.092.664.948.4
TOTAL REVENUES29,589.740,299.049,756.359,497.9
Cost of Goods Sold9,918.313,454.018,816.821,378.8
GROSS PROFIT19,671.426,845.130,939.438,119.1
Selling General & Admin Expenses, Total5,101.76,289.016,298.819,402.2
R&D Expenses----1,072.31,414.3
Depreciation & Amortization, Total946.8978.81,270.12,168.0
Other Operating Expenses8,546.013,318.62,522.03,298.9
OTHER OPERATING EXPENSES, TOTAL14,594.420,586.321,163.226,283.3
OPERATING INCOME5,077.06,258.89,776.211,835.8
Interest Expense-1,604.5-1,465.7-1,600.1-1,885.9
Interest and Investment Income39.089.142.666.4
NET INTEREST EXPENSE-1,565.6-1,376.5-1,557.5-1,819.5
Currency Exchange Gains (Loss)1,300.5---332.2-96.1
Other Non-Operating Income (Expenses)-----496.4-776.0
EBT, EXCLUDING UNUSUAL ITEMS4,811.84,882.27,390.19,144.1
Gain (Loss) on Sale of Investments----0.0--
Gain (Loss) on Sale of Assets3.5-1.3----
Other Unusual Items, Total-------2,175.4
Legal Settlements-------2,175.4
EBT, INCLUDING UNUSUAL ITEMS4,815.44,880.97,390.16,968.8
Income Tax Expense237.0237.81,107.21,512.7
Minority Interest in Earnings-46.2-39.6-82.6-33.3
Earnings from Continuing Operations4,578.34,643.16,282.95,456.0
NET INCOME4,532.14,603.56,200.35,422.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4,532.14,603.56,200.35,422.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4,532.14,603.56,200.35,422.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 705.85 INR -0.85

GNP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ANI Pharmaceuticals Inc $27.79 USD 0.00
Jubilant Life Sciences Ltd 151.70 INR +0.40
Lannett Co Inc $43.92 USD 0.00
Ranbaxy Laboratories Ltd 591.75 INR -1.85
ScripsAmerica Inc $0.10 USD 0.00
View Industry Companies
 

Industry Analysis

GNP

Industry Average

Valuation GNP Industry Range
Price/Earnings 31.5x
Price/Sales 3.0x
Price/Book 6.3x
Price/Cash Flow 22.3x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.